LATEST
Intelligent Protection Management agreed to acquire AdTech ITnewJanel agreed to acquire EnCor BiotechnologyNightfood Holdings acquired Jun Long Machine IndustrialClimb Global Solutions acquired NeoVADValor Energy agreed to acquire Glorious StarOakley Capital / Global Loan Agency ServicesTA Associates / MedEnvision: majority stakeLSEG agreed to acquire OctusStord / AMS Fulfillment: investmentCencora agreed to acquire American Oncology NetworkAPEX / KoraiSmith & Wesson Brands agreed to acquire Long Range Intermediate
Open App
ClosedPublished 12 Jan 2022

AcelRx Pharmaceuticals, Inc. /
Lowell Therapeutics, Inc.

AcelRx completes acquisition of Lowell Therapeutics

Terms
Not stated
Stage
Closed
Source · 12 Jan 2022
See the source
01 / BuyerAcelRx Pharmaceuticals, Inc.
02 / TargetLowell Therapeutics, Inc.
01

What happened

AcelRx Pharmaceuticals, Inc. completed its acquisition of Lowell Therapeutics, Inc. on Jan. 7, 2022. The transaction provided Lowell stockholders and option holders with AcelRx shares, cash and contingent value rights.

The cash consideration included $3,519,129.76, with additional contingent value rights tied to regulatory milestones and sales.

02

The source

Everything on this page comes from the source below.

01
Source · Source

AcelRx completes acquisition of Lowell Therapeutics

This document is the source for the companies, stage and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Closed

    The source this page is built from.

  2. Published by the source

    The source this page is built from.

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request accessAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.